These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16014120)

  • 21. Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer.
    Yunokawa M; Yoshida H; Watanabe R; Noguchi E; Shimomura A; Shimoi T; Yonemori K; Shimizu C; Fujiwara Y; Tamura K
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):127-134. PubMed ID: 28540420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
    Greenwald ZR; Huang LN; Wissing MD; Franco EL; Gotlieb WH
    Cancer; 2017 May; 123(9):1545-1554. PubMed ID: 28026855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged long-term survival of low-grade endometrial stromal sarcoma patients with lung metastasis following treatment with medroxyprogesterone acetate.
    Nakayama K; Ishikawa M; Nagai Y; Yaegashi N; Aoki Y; Miyazaki K
    Int J Clin Oncol; 2010 Apr; 15(2):179-83. PubMed ID: 20217451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
    Hahn HS; Yoon SG; Hong JS; Hong SR; Park SJ; Lim JY; Kwon YS; Lee IH; Lim KT; Lee KH; Shim JU; Mok JE; Kim TJ
    Int J Gynecol Cancer; 2009 Aug; 19(6):1068-73. PubMed ID: 19820370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A patient with stage 1a endometrial carcinoma in whom a solitary recurrent lesion was detected in the external iliac lymph node after MPA therapy.
    Takahashi N; Hirashima Y; Harashima S; Takekuma M; Kawaguchi R; Yamada Y; Ito I
    Arch Gynecol Obstet; 2008 Oct; 278(4):365-7. PubMed ID: 18273628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
    Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Seong SJ; Kim TJ; Kim JW; Kim SM; Bae DS; Nam JH
    Eur J Cancer; 2013 Mar; 49(4):868-74. PubMed ID: 23072814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unsuspected uterine carcinosarcoma (heterologous) diagnosed following conservative therapies with medroxyprogesterone acetate for presumed early-stage endometrial carcinoma.
    Fujiwara H; Shibahara H; Usui R; Takamizawa S; Kosuge S; Ohwada M; Suzuki M; Sato I
    Am J Reprod Immunol; 2002 Mar; 47(3):129-31. PubMed ID: 12069197
    [No Abstract]   [Full Text] [Related]  

  • 28. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
    Yang YC; Wu CC; Chen CP; Chang CL; Wang KL
    Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fertility-preserving treatment in young women with endometrial adenocarcinoma: a long-term cohort study.
    Wang CJ; Chao A; Yang LY; Hsueh S; Huang YT; Chou HH; Chang TC; Lai CH
    Int J Gynecol Cancer; 2014 May; 24(4):718-28. PubMed ID: 24577149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary hormonal treatment for early endometrial carcinoma.
    Sardi J; Anchezar Henry JP; Paniceres G; Gomez Rueda N; Vighi S
    Eur J Gynaecol Oncol; 1998; 19(6):565-8. PubMed ID: 10215442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrioid endometrial adenocarcinoma with psammoma bodies.
    Parkash V; Carcangiu ML
    Am J Surg Pathol; 1997 Apr; 21(4):399-406. PubMed ID: 9130986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful pregnancy after conservative surgery for stage IA endometrial cancer in a young woman.
    Yasuda M; Terai Y; Sekijima T; Sasaki H; Yamashita Y; Kanemura M; Ohmichi M
    Fertil Steril; 2009 Mar; 91(3):936.e13-5. PubMed ID: 19062001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term conservative therapy for endometrial adenocarcinoma in young women.
    Yahata T; Fujita K; Aoki Y; Tanaka K
    Hum Reprod; 2006 Apr; 21(4):1070-5. PubMed ID: 16361282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy.
    Saegusa M; Hamano M; Kuwata T; Yoshida T; Hashimura M; Akino F; Watanabe J; Kuramoto H; Okayasu I
    Cancer Sci; 2003 Jan; 94(1):103-11. PubMed ID: 12708483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Conservative treatment of endometrial cancer as a way to preserve fertility. Five-year experience at Instituto Nacional de Perinatilogía Isidro Espinoza de los Reyes].
    Arteaga Gómez AC; Castellanos Barroso G; Márquez Acosta G
    Ginecol Obstet Mex; 2012 Jun; 80(6):394-9. PubMed ID: 22826967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment.
    Huang SY; Jung SM; Ng KK; Chang YC; Lai CH
    Gynecol Oncol; 2005 May; 97(2):652-5. PubMed ID: 15863173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
    Park JY; Seong SJ; Kim TJ; Kim JW; Kim SM; Bae DS; Nam JH
    Obstet Gynecol; 2013 Jan; 121(1):136-42. PubMed ID: 23262938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
    Yamagami W; Susumu N; Makabe T; Sakai K; Nomura H; Kataoka F; Hirasawa A; Banno K; Aoki D
    J Gynecol Oncol; 2018 Mar; 29(2):e21. PubMed ID: 29400014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy.
    Gunderson CC; Dutta S; Fader AN; Maniar KP; Nasseri-Nik N; Bristow RE; Diaz-Montes TP; Palermo R; Kurman RJ
    Gynecol Oncol; 2014 Jan; 132(1):33-7. PubMed ID: 24316307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma.
    Watanabe J; Watanabe K; Jobo T; Kamata Y; Kawaguchi M; Imai M; Okayasu I; Kuramoto H
    Int J Gynecol Cancer; 2006; 16 Suppl 1():452-7. PubMed ID: 16515645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.